Impax Laboratories

Impax Laboratories, Inc. is a technology-based specialty Pharmaceutical company applying its formulation expertize and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.
Type
Public
HQ
Hayward, US
Founded
1999
Size (employees)
1,495 (est)+16%
Impax Laboratories was founded in 1999 and is headquartered in Hayward, US

Impax Laboratories Office Locations

Impax Laboratories has offices in Hayward, Philadelphia, Chalfont and Zhunan Township
Hayward, US (HQ)
30831 Huntwood Ave
Zhunan Township, TW
No. 1, Ke Dong 3rd Road Jhunan Science Park Miaoli County 350
Chalfont, US
121 New Britain Blvd
Philadelphia, US
3735 Castor Ave

Impax Laboratories Metrics

Impax Laboratories Financial Metrics

Revenue (2016)

$824.4 m

Revenue growth (2015-16), %

(4%)

Net income (2016)

($472 m)

Market capitalization (21-Mar-2017)

$645.7 m

Closing share price (21-Mar-2017)

$9.2

Cash (31-Dec-2015)

$340.4 m
Impax Laboratories's current market capitalization is $645.7 m.
Impax Laboratories's revenue was reported to be $824.4 m in FY, 2016 which is a 4% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$511.5 m$596 m$860.5 m$824.4 m

Revenue growth, %

17%44%(4%)

Cost of goods sold

$312.2 m$283.4 m$508.1 m

Gross profit

$199.3 m$312.7 m$352.4 m

Gross profit Margin, %

39%52%41%

Operating expense total

$205.7 m$223.8 m$282.8 m

EBIT

($6.4 m)$88.8 m$69.6 m

EBIT margin, %

(1%)15%8%

Interest expense

($419 k)($43 k)($27.3 m)

Interest income

$1.3 m$1.5 m$1 m

Pre tax profit

$146.9 m$90.6 m$59.4 m

Income tax expense

$45.7 m$33.2 m$20.4 m

Net Income

$101.3 m$57.4 m$39 m($472 m)
FY, 2013FY, 2014FY, 2015

Cash

$184.6 m$214.9 m$340.4 m

Accounts Receivable

$113 m$146.5 m$324.5 m

Inventories

$12.7 m$33.7 m$31.7 m

Current Assets

$659.7 m$730.5 m$822.1 m

PP&E

$188.2 m$188.2 m$214.2 m

Goodwill

$27.6 m$27.6 m$210.2 m

Total Assets

$996.9 m$1.1 b$1.9 b

Accounts Payable

$26.8 m$32 m$56.3 m

Current Liabilities

$153.9 m$158.7 m$326.8 m

Additional Paid-in Capital

$336.6 m$364.1 m$504.1 m

Retained Earnings

$473.9 m$531.2 m$570.2 m

Total Equity

$1.1 b

Financial Leverage

1.8 x
FY, 2013FY, 2014FY, 2015

Net Income

$101.3 m$57.4 m$39 m

Depreciation and Amortization

$36 m$34 m$68.6 m

Accounts Receivable

($21 m)($33 m)($120 m)

Inventories

$7.1 m($24 m)($5.9 m)

Accounts Payable

$4.7 m($9 m)$48.1 m

Cash From Operating Activities

$149.9 m$32.8 m$71.9 m

Purchases of PP&E

($32.8 m)($29.9 m)($25.2 m)

Cash From Investing Activities

($115.9 m)($16.6 m)($467.5 m)

Cash From Financing Activities

$9 m$14.4 m$521.4 m

Interest Paid

$89 k$15.4 m

Income Taxes Paid

$34.3 m$43.2 m

Impax Laboratories Market Value History

Impax Laboratories Median Salaries

Source: 25 public H-1B filings from Impax Laboratories

Impax Laboratories Company Life

You may also be interested in